セオドラ

Recent publications · Crossref

5 total works indexed

1. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

   · 2007 · cited 2,975x

2. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   · 2019 · cited 2,544x

3. Protective Groups in Organic Synthesis

   · 1999 · cited 1,985x

4. Convergent antibody responses to SARS-CoV-2 in convalescent individuals

   · 2020 · cited 1,826x

5. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

   · 2024 · cited 1,794x

via Crossref · CC0

Wikidata facts

via Wikidata · CC0